Its not quarter on quarter growth, its PCP growth. If we get 33% PCP growth each quarter than our annual growth will be 33% which is poor for a 'breakthrough' product.
Perhaps new hospitals are getting there first order free or something?
And what is the story with Europe? I get that ahz is operating poorly there but surely the products are being requested by surgeons by now?
Its not quarter on quarter growth, its PCP growth. If we get 33%...
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |